These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 24300620)

  • 41. Pharmacological therapies for acute respiratory distress syndrome.
    Spieth PM; Zhang H
    Curr Opin Crit Care; 2014 Feb; 20(1):113-21. PubMed ID: 24335654
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paracrine effects and heterogeneity of marrow-derived stem/progenitor cells: relevance for the treatment of respiratory diseases.
    Conese M; Carbone A; Castellani S; Di Gioia S
    Cells Tissues Organs; 2013; 197(6):445-73. PubMed ID: 23652321
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury.
    Martínez-González I; Roca O; Masclans JR; Moreno R; Salcedo MT; Baekelandt V; Cruz MJ; Rello J; Aran JM
    Am J Respir Cell Mol Biol; 2013 Oct; 49(4):552-62. PubMed ID: 23656573
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Advances in Stem Cell and Cell-Based Gene Therapy Approaches for Experimental Acute Lung Injury: A Review of Preclinical Studies.
    Mei SH; Dos Santos CC; Stewart DJ
    Hum Gene Ther; 2016 Oct; 27(10):802-812. PubMed ID: 27531647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and Modulation of Microenvironment Is Crucial for Effective Mesenchymal Stromal Cell Therapy in Acute Lung Injury.
    Islam D; Huang Y; Fanelli V; Delsedime L; Wu S; Khang J; Han B; Grassi A; Li M; Xu Y; Luo A; Wu J; Liu X; McKillop M; Medin J; Qiu H; Zhong N; Liu M; Laffey J; Li Y; Zhang H
    Am J Respir Crit Care Med; 2019 May; 199(10):1214-1224. PubMed ID: 30521764
    [No Abstract]   [Full Text] [Related]  

  • 46. Improved cell survival and paracrine capacity of human embryonic stem cell-derived mesenchymal stem cells promote therapeutic potential for pulmonary arterial hypertension.
    Zhang Y; Liao S; Yang M; Liang X; Poon MW; Wong CY; Wang J; Zhou Z; Cheong SK; Lee CN; Tse HF; Lian Q
    Cell Transplant; 2012; 21(10):2225-39. PubMed ID: 22776744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Spontaneous breathing activity in acute lung injury and acute respiratory distress syndrome.
    Gama de Abreu M; Güldner A; Pelosi P
    Curr Opin Anaesthesiol; 2012 Apr; 25(2):148-55. PubMed ID: 22227446
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Regenerative cell and tissue-based therapies for pulmonary arterial hypertension.
    Foster WS; Suen CM; Stewart DJ
    Can J Cardiol; 2014 Nov; 30(11):1350-60. PubMed ID: 25442435
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Mesenchymal stem cells in acute kidney injury.
    Humphreys BD; Bonventre JV
    Annu Rev Med; 2008; 59():311-25. PubMed ID: 17914926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mobilization of endothelial progenitor cells from bone marrow is impaired in a piglet model of acute respiratory distress syndrome.
    Qi Y; Qian L; Sun B; Wang Y; Liu L; Wu P; Sun L
    Pediatr Crit Care Med; 2013 Jun; 14(5):e233-42. PubMed ID: 23867444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacotherapy for acute respiratory distress syndrome.
    Shafeeq H; Lat I
    Pharmacotherapy; 2012 Oct; 32(10):943-57. PubMed ID: 23033233
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential of cell-based therapy in lung diseases.
    Huleihel L; Levine M; Rojas M
    Expert Opin Biol Ther; 2013 Oct; 13(10):1429-40. PubMed ID: 23984902
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Updates in the management of acute lung injury: a focus on the overlap between AKI and ARDS.
    Seeley EJ
    Adv Chronic Kidney Dis; 2013 Jan; 20(1):14-20. PubMed ID: 23265592
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mesenchymal stem cells and acute lung injury.
    Gotts JE; Matthay MA
    Crit Care Clin; 2011 Jul; 27(3):719-33. PubMed ID: 21742225
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Genetically modified mesenchymal stem cell therapy for acute respiratory distress syndrome.
    Han J; Liu Y; Liu H; Li Y
    Stem Cell Res Ther; 2019 Dec; 10(1):386. PubMed ID: 31843004
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biological therapies in the acute respiratory distress syndrome.
    Boyle AJ; McNamee JJ; McAuley DF
    Expert Opin Biol Ther; 2014 Jul; 14(7):969-81. PubMed ID: 24702248
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Concise review: adult mesenchymal stromal cell therapy for inflammatory diseases: how well are we joining the dots?
    Griffin MD; Elliman SJ; Cahill E; English K; Ceredig R; Ritter T
    Stem Cells; 2013 Oct; 31(10):2033-41. PubMed ID: 23766124
    [TBL] [Abstract][Full Text] [Related]  

  • 58. What is the acute respiratory distress syndrome?
    Villar J
    Respir Care; 2011 Oct; 56(10):1539-45. PubMed ID: 22008395
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alveolar Fluid Clearance in Pathologically Relevant Conditions:
    Huppert LA; Matthay MA
    Front Immunol; 2017; 8():371. PubMed ID: 28439268
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Therapeutic effects of bone marrow-derived mesenchymal stem cells on pulmonary impact injury complicated with endotoxemia in rats.
    Zhao Y; Yang C; Wang H; Li H; Du J; Gu W; Jiang J
    Int Immunopharmacol; 2013 Feb; 15(2):246-53. PubMed ID: 23273653
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.